Female | Male | Total | |
Total | 40 | 48 | 88* |
Age range (years) | |||
1–14 | 12 | 18 | 30 |
15–17 | 28 | 30 | 58 |
Injury mechanism | |||
Routine use of vaping device or device malfunction | 32 | 43 | 75 |
Ingestion of vaping product† | 8 | 5 | 13 |
Substance‡ | |||
Flavouring | 9 | 13 | 22 |
Nicotine | 14 | 19 | 33 |
Cannabis | 6 | 15 | 21 |
Unknown | 17 | 16 | 33 |
No response | 5 | 7 | 12 |
Clinical presentation‡ | |||
Respiratory distress/lung injury | 22 | 17 | 39 |
Mouth or throat irritation and/or burn | *§ | * | 6 |
Abdominal pain/nausea/vomiting | * | * | 9 |
Symptoms of nicotine toxicity (other than nausea/vomiting) | * | * | 15 |
Central nervous system depression/altered mental status | * | * | 9 |
Other¶ | * | * | 13 |
No response | 6 | 7 | 13 |
Treatment location‡ | |||
Walk-in/outpatient clinic | 7 | 8 | 15 |
Emergency department | 10 | 18 | 28 |
Hospital ward | 10 | 12 | 22 |
Intensive care unit** | * | * | 13 |
Referred to specialist | * | * | 5 |
No response | 10 | 13 | 23 |
Patient outcome | |||
Full recovery | 16 | 19 | 35 |
Ongoing health issues | 9 | 7 | 16 |
Unknown | 5 | 8 | 13 |
No response | 10 | 14 | 24 |
*There were no duplicate cases.
†Fewer than five cases of injuries caused by the ingestion of a vaping product required intensive care unit admission.
‡Respondents could select more than one option.
§Asterisk indicates that one or both sex subgroup cells contain fewer than five participants (exact number may not be disclosed due to confidentiality concerns).
¶Other symptoms included: injury to upper limbs or torso, head or neck burn, eye injury/vision loss, and other (unspecified).
**Of the cases requiring intensive care unit admission, fewer than five had ongoing health issues.